| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Research and development | $214.7M+27.9% | $167.9M+145.3% | $68.4M+146.3% | $27.8M |
| General and administrative | $70.9M+44.6% | $49.0M+99.4% | $24.6M+735.7% | $2.9M |
| Total operating expenses | $285.6M+31.7% | $216.9M+133.2% | $93.0M+202.7% | $30.7M |
| Loss from operations | -$285.6M-31.7% | -$216.9M-133.2% | -$93.0M-202.7% | -$30.7M |
| Interest income, net | $30.0M-13.6% | $34.7M+285.3% | $9.0M+9702.2% | $92K |
| Total other income, net | $30.0M-13.6% | $34.7M+285.3% | $9.0M+199.6% | -$9.1M |
| Net loss before taxes | -$255.6M-40.3% | -$182.1M-116.9% | -$84.0M | — |
| Provision for income taxes | -$278K-1444.4% | -$18K | $0 | — |
| Net loss after taxes | -$255.8M-40.5% | -$182.1M-116.9% | -$84.0M-111.1% | -$39.8M |
| Net loss per share, basic | -$4220.00-27.9% | -$3300.00+1.8% | -$3360.00+79.2% | -$16160.00 |
| Net loss per share, diluted | -$4220.00-27.9% | -$3300.00+1.8% | -$3360.00+79.2% | -$16160.00 |
| Weighted-average common shares outstanding, basic | 60.69B+10.0% | 55.19B+120.7% | 25.01B+915.6% | 2.46B |
| Weighted-average common shares outstanding, diluted | 60.69B+10.0% | 55.19B+120.7% | 25.01B+915.6% | 2.46B |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.